Southport Management, L.L.C. Immuneering Corp Transaction History
Southport Management, L.L.C.
- $27.6 Billion
- Q4 2024
A detailed history of Southport Management, L.L.C. transactions in Immuneering Corp stock. As of the latest transaction made, Southport Management, L.L.C. holds 215,000 shares of IMRX stock, worth $359,050. This represents 1.71% of its overall portfolio holdings.
Number of Shares
215,000
Previous 205,000
4.88%
Holding current value
$359,050
Previous $510 Million
7.34%
% of portfolio
1.71%
Previous 1.9%
Shares
5 transactions
Others Institutions Holding IMRX
# of Institutions
44Shares Held
4.59MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.77 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD767KShares$1.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$890,7170.0% of portfolio
-
Morgan Stanley New York, NY454KShares$758,3470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA208KShares$348,0060.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $44.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...